Records for this company (1 joined by official identifier) Every record below is joined to this company by a hard identifier: its SEC registrant record or its GLEIF ownership tree. Each line says how. Built 2026-11-18 13:42:42. Beta: records that match only by name are held apart until name matching is verified.
SEC EDGAR (1) 3 VALUES · 10-Q · EACH LINKS TO ITS FILING
Latest quarter Latest report: 10-Q for the period ended 2026-09-30 , filed 2026-11-16 · accession 0002094256-26-000007
Negative as reported in the filing.
Not in this report's XBRL: Revenue.
Values as filed in XBRL (SEC company facts ); quarterly values are the filer's 3-month figures, never derived.
Identifiers
SEC CIK 0002094256
Ticker CLYD
Record ID sx:sec:0002094256 OTHER SITES · YOUR CLICK · THEY SHOW THEIR OWN DATA
Open in Open in… Analyst estimates and earnings Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.
13 FACTS · EACH LINKS TO ITS FILING
Facts Fact Value As of Source Retrieved Report SEC entity type operating 2026-11-20 SEC EDGAR company profile 2026-11-22 01:16 UTC Report an error SIC industry 2834 Pharmaceutical Preparations 2026-11-20 SEC EDGAR company profile 2026-11-22 01:16 UTC Report an error State of incorporation DE 2026-11-20 SEC EDGAR company profile 2026-11-22 01:16 UTC Report an error Fiscal year end (MMDD) 1231 2026-11-20 SEC EDGAR company profile 2026-11-22 01:16 UTC Report an error Business address 20400 CENTURY BOULEVARD, SUITE 210, GERMANTOWN, MD, 20874 2026-11-20 SEC EDGAR company profile 2026-11-22 01:16 UTC Report an error 8-K Item 2.01, Completion of Acquisition or Disposition of Assets (filed 2026-11-20) The information contained in the Introductory Note of this Form 8-K is incorporated by reference into this Item 2.01. Pursuant to the Merger Agreement, the Combinations were implemented as follows: (i) on September 9, 2026, the Company acquired the entire issued and to be issued share capital of Barinthus Bio pursuant to (a) the Scheme of Arrangement, (b) a share purchase agreement pursuant to which the deferred A shares in the capital of Barinthus Bio were acquired by the Company upon effectiveness of the Scheme of Arrangement, and (c) the Merger Agreement (such transaction, together with the Scheme of Arrangement, the “Scheme Transaction”), resulting in Barinthus Bio becoming a direct… 2026-11-20 SEC EDGAR 8-K 0001104659-26-130676 (text as filed, excerpt) 2026-11-22 01:16 UTC Report an error 8-K Item 3.01, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (filed 2026-11-20) The information set forth in Item 2.01 of this Form 8-K is incorporated by reference into this Item 3.01. 2026-11-20 SEC EDGAR 8-K 0001104659-26-130676 (text as filed, excerpt) 2026-11-22 01:16 UTC Report an error 8-K Item 3.03, Material Modification to Rights of Security Holders (filed 2026-11-20) The information set forth in Items 2.01 and 5.03 of this Form 8-K is incorporated by reference into this Item 3.03. As previously disclosed, upon consummation of the Scheme Transaction, each Scheme Share was exchanged for the Scheme Consideration. Upon consummation of the Merger, each share of Clywedog Common Stock and Clywedog Preferred Stock was converted into the Merger Consideration. As a result of the Combinations, former Barinthus Bio shareholders own approximately 34% and former Clywedog stockholders own approximately 66% of the Company on a fully diluted basis. Each share of Common Stock is issued pursuant to, and carries with it the rights and obligations set forth in, the Amended… 2026-11-20 SEC EDGAR 8-K 0001104659-26-130676 (text as filed, excerpt) 2026-11-22 01:16 UTC Report an error 8-K Item 5.01, Changes in Control of Registrant (filed 2026-11-20) The information set forth in Item 2.01 of this Form 8-K is incorporated by reference into this Item 5.01. 2026-11-20 SEC EDGAR 8-K 0001104659-26-130676 (text as filed, excerpt) 2026-11-22 01:16 UTC Report an error 8-K Item 5.02, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of (filed 2026-11-20) Certain Officers. Resignation of Director and Appointment of Directors of the Company Immediately prior to the appointment of the below-mentioned members of the Company’s board of directors, Nick Fullenkamp resigned as a director of the Company. Mr. Fullenkamp’s resignation was not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices. Pursuant to the Merger Agreement, Clywedog was entitled to designate at least 2/3 of the directors of the Company prior to the Merger Effective Time, and Barinthus Bio was entitled to designate at least 1/3 of the directors of the Company prior to the Merger Effective Time. At the Merger… 2026-11-20 SEC EDGAR 8-K 0001104659-26-130676 (text as filed, excerpt) 2026-11-22 01:16 UTC Report an error 8-K Item 5.03, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year (filed 2026-11-20) Certificate of Amendment – Name Change On November 20, 2026, in connection with the consummation of the Merger, the Company filed a Certificate of Amendment to the A&R Certificate of Incorporation (the “Certificate of Amendment”) with the Secretary of State of the State of Delaware to change the Company’s corporate name from “Beacon Topco, Inc.” to “Clywedog Therapeutics Holdings, Inc.” The Certificate of Amendment became effective upon filing. The foregoing description of the Certificate of Amendment does not purport to be complete and is qualified in its entirety by reference to the full text of the Certificate of Amendment, a copy of which is filed as Exhibit 3.2 hereto and is… 2026-11-20 SEC EDGAR 8-K 0001104659-26-130676 (text as filed, excerpt) 2026-11-22 01:16 UTC Report an error 8-K Item 3.03, Material Modification to Rights of Security Holders (filed 2026-09-17) The information set forth in Item 5.03 of this Current Report on Form 8-K is incorporated herein by reference into this Item 3.03. 2026-09-17 SEC EDGAR 8-K 0001104659-26-108353 (text as filed, excerpt) 2026-11-22 01:16 UTC Report an error 8-K Item 5.03, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year (filed 2026-09-17) The information set forth in the Introductory Note of this Current Report on Form 8-K is incorporated herein by reference into this Item 5.03. As previously described in the proxy statement/prospectus contained in the Company's Registration Statement on Form S-4, as amended (File No. 333-291359), in connection with the Transaction and the Offer, the Company adopted an amended and restated certificate of incorporation (the "A&R Charter") and amended and restated bylaws (the "A&R Bylaws"). The A&R Charter became effective upon its filing with the Secretary of State of the State of Delaware on September 9, 2026. The A&R Bylaws became effective on September 8, 2026. The foregoing description… 2026-09-17 SEC EDGAR 8-K 0001104659-26-108353 (text as filed, excerpt) 2026-11-22 01:16 UTC Report an error
EVERY DATED RECORD, NEWEST FIRST
Timeline All (20) Filing (20)
Gaps Court records: not covered yet (expected 11-19). SEC: no annual XBRL financial data No EIN on the SEC filing, so no Form 990 lookup SEC 13F holders: no CUSIP stated in a Schedule 13G/13D for this company USAspending: no recipient whose SAM legal name and address match this SEC filer Sources SEC EDGAR: checked · 2026-11-22T01:16:55Z Propublica 990: checked, nothing found · 2026-11-22T01:16:55Z SEC 13F holdings: checked, nothing found · 2026-11-22T01:16:55Z USAspending: checked, nothing found · 2026-11-22T01:16:56Z CC BY 4.0 -- credit Seraphix Systems.
Use this record Records are free to read and reuse under CC BY 4.0 -- credit Seraphix Systems. The same records as JSON: GET /v1/search?q= and GET /v1/record/<id> (without a key, up to 50 record lookups a day per visitor). No key: single records, pages, feeds and bulk files are free; cross-company search and the live stream cost $0.002 a call via x402. Free key: 100 calls a month, no card. Get a free key or a paid key ; send Authorization: Bearer <key>.